vs
FIRST US BANCSHARES, INC.（FUSB）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
FIRST US BANCSHARES, INC.的季度营收约是Protalix BioTherapeutics, Inc.的1.1倍（$10.4M vs $9.1M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -60.3%，领先80.8%），FIRST US BANCSHARES, INC.同比增速更快（7.1% vs -49.9%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $1.6M），过去两年FIRST US BANCSHARES, INC.的营收复合增速更高（2.6% vs -6.7%）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
FUSB vs PLX — 直观对比
营收规模更大
FUSB
是对方的1.1倍
$9.1M
营收增速更快
FUSB
高出57.0%
-49.9%
净利率更高
FUSB
高出80.8%
-60.3%
自由现金流更多
FUSB
多$7.5M
$1.6M
两年增速更快
FUSB
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $9.1M |
| 净利润 | $2.1M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | 28.1% | -51.1% |
| 净利率 | 20.4% | -60.3% |
| 营收同比 | 7.1% | -49.9% |
| 净利润同比 | 24.2% | -184.8% |
| 每股收益（稀释后） | $0.36 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUSBPLX
| Q4 25 | $10.4M | $9.1M | ||
| Q3 25 | $10.5M | $17.9M | ||
| Q2 25 | $10.3M | $15.7M | ||
| Q1 25 | $9.8M | $10.1M | ||
| Q4 24 | $9.7M | $18.2M | ||
| Q3 24 | $10.1M | $18.0M | ||
| Q2 24 | $10.0M | $13.5M | ||
| Q1 24 | $9.9M | — |
净利润FUSBPLX
| Q4 25 | $2.1M | $-5.5M | ||
| Q3 25 | $1.9M | $2.4M | ||
| Q2 25 | $155.0K | $164.0K | ||
| Q1 25 | $1.8M | $-3.6M | ||
| Q4 24 | $1.7M | $6.5M | ||
| Q3 24 | $2.2M | $3.2M | ||
| Q2 24 | $2.1M | $-2.2M | ||
| Q1 24 | $2.1M | — |
毛利率FUSBPLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
营业利润率FUSBPLX
| Q4 25 | 28.1% | -51.1% | ||
| Q3 25 | 23.9% | 11.9% | ||
| Q2 25 | 1.6% | 7.5% | ||
| Q1 25 | 23.8% | -41.0% | ||
| Q4 24 | 23.8% | 39.6% | ||
| Q3 24 | 29.2% | 22.2% | ||
| Q2 24 | 27.4% | -18.0% | ||
| Q1 24 | 27.8% | — |
净利率FUSBPLX
| Q4 25 | 20.4% | -60.3% | ||
| Q3 25 | 18.4% | 13.2% | ||
| Q2 25 | 1.5% | 1.0% | ||
| Q1 25 | 18.1% | -35.8% | ||
| Q4 24 | 17.6% | 35.6% | ||
| Q3 24 | 22.0% | 18.0% | ||
| Q2 24 | 21.2% | -16.4% | ||
| Q1 24 | 21.3% | — |
每股收益（稀释后）FUSBPLX
| Q4 25 | $0.36 | $-0.06 | ||
| Q3 25 | $0.32 | $0.03 | ||
| Q2 25 | $0.03 | $0.00 | ||
| Q1 25 | $0.29 | $-0.05 | ||
| Q4 24 | $0.29 | $0.10 | ||
| Q3 24 | $0.36 | $0.03 | ||
| Q2 24 | $0.34 | $-0.03 | ||
| Q1 24 | $0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $14.7M |
| 总债务越低越好 | $10.9M | — |
| 股东权益账面价值 | $105.6M | $48.2M |
| 总资产 | $1.2B | $82.3M |
| 负债/权益比越低杠杆越低 | 0.10× | — |
8季度趋势，按日历期对齐
现金及短期投资FUSBPLX
| Q4 25 | $73.5M | $14.7M | ||
| Q3 25 | $54.7M | $13.6M | ||
| Q2 25 | $54.0M | $17.9M | ||
| Q1 25 | $56.0M | $19.5M | ||
| Q4 24 | $47.2M | $19.8M | ||
| Q3 24 | $82.3M | $27.4M | ||
| Q2 24 | $58.2M | $23.4M | ||
| Q1 24 | $60.2M | — |
总债务FUSBPLX
| Q4 25 | $10.9M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $10.9M | — | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $10.9M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $10.8M | — |
股东权益FUSBPLX
| Q4 25 | $105.6M | $48.2M | ||
| Q3 25 | $104.2M | $52.9M | ||
| Q2 25 | $101.9M | $49.9M | ||
| Q1 25 | $101.2M | $45.2M | ||
| Q4 24 | $98.6M | $43.2M | ||
| Q3 24 | $98.5M | $32.4M | ||
| Q2 24 | $93.8M | $28.6M | ||
| Q1 24 | $92.3M | — |
总资产FUSBPLX
| Q4 25 | $1.2B | $82.3M | ||
| Q3 25 | $1.1B | $82.3M | ||
| Q2 25 | $1.1B | $78.5M | ||
| Q1 25 | $1.1B | $73.9M | ||
| Q4 24 | $1.1B | $73.4M | ||
| Q3 24 | $1.1B | $61.6M | ||
| Q2 24 | $1.1B | $91.5M | ||
| Q1 24 | $1.1B | — |
负债/权益比FUSBPLX
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $1.6M |
| 自由现金流率自由现金流/营收 | 87.2% | 17.8% |
| 资本支出强度资本支出/营收 | 31.1% | 4.4% |
| 现金转化率经营现金流/净利润 | 5.79× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流FUSBPLX
| Q4 25 | $12.3M | $2.0M | ||
| Q3 25 | $4.2M | $-3.7M | ||
| Q2 25 | $3.9M | $-5.2M | ||
| Q1 25 | $1.8M | $-5.1M | ||
| Q4 24 | $7.8M | $4.0M | ||
| Q3 24 | $1.9M | $4.1M | ||
| Q2 24 | $2.5M | $-3.6M | ||
| Q1 24 | $825.0K | — |
自由现金流FUSBPLX
| Q4 25 | $9.1M | $1.6M | ||
| Q3 25 | $3.6M | $-4.2M | ||
| Q2 25 | $1.6M | $-5.7M | ||
| Q1 25 | $1.7M | $-5.4M | ||
| Q4 24 | $5.7M | $3.6M | ||
| Q3 24 | $1.3M | $4.0M | ||
| Q2 24 | $2.3M | $-3.8M | ||
| Q1 24 | $-142.0K | — |
自由现金流率FUSBPLX
| Q4 25 | 87.2% | 17.8% | ||
| Q3 25 | 34.2% | -23.7% | ||
| Q2 25 | 16.0% | -36.2% | ||
| Q1 25 | 17.2% | -53.0% | ||
| Q4 24 | 58.2% | 19.6% | ||
| Q3 24 | 12.7% | 22.4% | ||
| Q2 24 | 23.5% | -28.1% | ||
| Q1 24 | -1.4% | — |
资本支出强度FUSBPLX
| Q4 25 | 31.1% | 4.4% | ||
| Q3 25 | 5.9% | 2.8% | ||
| Q2 25 | 21.8% | 2.8% | ||
| Q1 25 | 0.7% | 3.0% | ||
| Q4 24 | 21.6% | 2.3% | ||
| Q3 24 | 6.6% | 0.5% | ||
| Q2 24 | 2.0% | 1.3% | ||
| Q1 24 | 9.8% | — |
现金转化率FUSBPLX
| Q4 25 | 5.79× | — | ||
| Q3 25 | 2.18× | -1.58× | ||
| Q2 25 | 25.16× | -31.91× | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | 0.61× | ||
| Q3 24 | 0.87× | 1.27× | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUSB
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
